首页> 外文OA文献 >ANALYSIS OF APPROACHES TO THE DEVELOPMENT AND VALIDATION OF THE METHODS OF ANALYSIS OF SOME ACTIVE PHARMACEUTICAL INGREDIENTS FROM THE GROUP OF CALCIUM CHANNEL BLOCKERS IN DRUGS AND BIOLOGICAL LIQUIDS

【2h】

ANALYSIS OF APPROACHES TO THE DEVELOPMENT AND VALIDATION OF THE METHODS OF ANALYSIS OF SOME ACTIVE PHARMACEUTICAL INGREDIENTS FROM THE GROUP OF CALCIUM CHANNEL BLOCKERS IN DRUGS AND BIOLOGICAL LIQUIDS

机译：从药物和生物液体中分析一些活性药物成分分析方法的开发和验证方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Liliya Logoyda;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Chemometrically assisted development and validation of LC-MS/MS method for the analysis of potential genotoxic impurities in meropenem active pharmaceutical ingredient [J] . Grigori Katerina, Loukas Yannis L., Malenovic Andelija, Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis . 2017,第期

机译：Meropenem活性药物成分中潜在遗传毒性杂质分析LC-MS / MS方法的化学辅助开发和验证
2. Development and validation of a high-resolution capillary electrophoresis method for multi-analysis of ragaglitazar and arginine in Active Pharmaceutical Ingredients and low-dose tablets. [J] . Jamali B, Lehmann S Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis . 2004,第3期

机译：开发和验证用于活性药物成分和小剂量片剂中的ragaglitazar和精氨酸的多重分析的高分辨率毛细管电泳方法。
3. METHOD DEVELOPMENT AND VALIDATION OF ULTRAVIOLET-VISIBLE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF HEPATITIS-C DRUGS - DACLATASVIR AND SOFOSBUVIR IN ACTIVE PHARMACEUTICAL INGREDIENT FORM [J] . V. Ashok Chakravarthy, Sailaja Bbv, Praveen Kumar A Asian Journal of Pharmaceutical and Clinical Research . 2016,第9期

机译：紫外-可见分光光度法测定活性药物成分肝炎-丙型药物-DACLATASVIR和SOFOSBUVIR的方法开发和验证
4. Estimation of Active Pharmaceutical Ingredients Content in Blending Process for Drug Products Manufacturing [C] . Sanghong Kim, Hiroshi Nakagawa, Manabu Kano, AIChE annual meeting . 2010

机译：药品生产混合过程中活性药物成分含量的估算
5. Method Development and Validation For Separation of Eight Pharmaceutical Active Ingredients Using Reversed- Phase Liquid Chromatography and Drylab RTM Modeling. [D] . Vasani, Jayeshkumar. 2017

机译：使用反相液相色谱和Drylab RTM建模分离八种药物活性成分的方法开发和验证。
6. Method development for simultaneous determination of active ingredients in cough and cold pharmaceuticals by high performance liquid chromatography [O] . Azizollah Nezhadali, Mahmoud Reza Shapouri, Mitra Amoli-Diva, 2019

机译：高效液相色谱法同时测定止咳药和感冒药中有效成分的方法开发
7. ANALYSIS OF APPROACHES TO THE DEVELOPMENT AND VALIDATION OF THE METHODS OF ANALYSIS OF SOME ACTIVE PHARMACEUTICAL INGREDIENTS FROM THE GROUP OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN DRUGS AND BIOLOGICAL LIQUIDS [O] . Liliya Logoyda 2019

机译：从药物和生物液体中血管紧张素转换酶抑制剂的一些活性药物成分分析方法的开发和验证方法

ANALYSIS OF APPROACHES TO THE DEVELOPMENT AND VALIDATION OF THE METHODS OF ANALYSIS OF SOME ACTIVE PHARMACEUTICAL INGREDIENTS FROM THE GROUP OF CALCIUM CHANNEL BLOCKERS IN DRUGS AND BIOLOGICAL LIQUIDS

著录项

引文网络

相似文献

相关主题

期刊订阅